Brief: Cara Therapeutics - Announced Appointment Of Ryan Maynard As Chief Financial Officer
12/09/2022 11:05
Sept 12 (Reuters) - Cara Therapeutics Inc CARA.O :
* CARA THERAPEUTICS - ON SEPT 12, 2022, CO ANNOUNCED
APPOINTMENT
OF RYAN MAYNARD TO SERVE AS CHIEF FINANCIAL OFFICER, EFFECTIVE
SEPTEMBER 12, 2022
Further company coverage: CARA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM